Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 2
1953 1
1956 1
1957 1
1975 1
1977 1
1978 1
1980 1
1981 1
1983 3
1984 2
1985 1
1986 2
1987 2
1988 1
1989 2
1990 3
1991 5
1992 2
1993 5
1994 4
1995 3
1996 10
1997 3
1998 3
1999 4
2000 4
2001 5
2002 6
2003 13
2004 10
2005 8
2006 14
2007 19
2008 23
2009 28
2010 32
2011 30
2012 32
2013 35
2014 37
2015 39
2016 36
2017 42
2018 29
2019 22
2020 7
2021 4
2022 7
2023 5
2024 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

479 results

Results by year

Filters applied: . Clear all
Page 1
Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, Garrido Ed Ede R, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R. Houssiau FA, et al. Among authors: galeazzi m. Arthritis Rheum. 2002 Aug;46(8):2121-31. doi: 10.1002/art.10461. Arthritis Rheum. 2002. PMID: 12209517 Free article. Clinical Trial.
Synovial Leishmaniasis.
Guidelli GM, De Stefano R, Galeazzi M, Selvi E. Guidelli GM, et al. Among authors: galeazzi m. Arthritis Rheumatol. 2016 Apr;68(4):931. doi: 10.1002/art.39541. Arthritis Rheumatol. 2016. PMID: 26663894 No abstract available.
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients.
Cervera R, Serrano R, Pons-Estel GJ, Ceberio-Hualde L, Shoenfeld Y, de Ramón E, Buonaiuto V, Jacobsen S, Zeher MM, Tarr T, Tincani A, Taglietti M, Theodossiades G, Nomikou E, Galeazzi M, Bellisai F, Meroni PL, Derksen RH, de Groot PG, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quéré I, Hachulla E, Vasconcelos C, Fernández-Nebro A, Haro M, Amoura Z, Miyara M, Tektonidou M, Espinosa G, Bertolaccini ML, Khamashta MA; Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies). Cervera R, et al. Among authors: galeazzi m. Ann Rheum Dis. 2015 Jun;74(6):1011-8. doi: 10.1136/annrheumdis-2013-204838. Epub 2014 Jan 24. Ann Rheum Dis. 2015. PMID: 24464962 Free article.
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.
Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Lakos G, Tincani A, Kontopoulou-Griva I, Galeazzi M, Meroni PL, Derksen RH, de Groot PG, Gromnica-Ihle E, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quéré I, Hachulla E, Vasconcelos C, Roch B, Fernández-Nebro A, Boffa MC, Hughes GR, Ingelmo M; Euro-Phospholipid Project Group. Cervera R, et al. Among authors: galeazzi m. Arthritis Rheum. 2002 Apr;46(4):1019-27. doi: 10.1002/art.10187. Arthritis Rheum. 2002. PMID: 11953980 Free article.
Autoinflammatory syndromes.
Galeazzi M, Gasbarrini G, Ghirardello A, Grandemange S, Hoffman HM, Manna R, Podswiadek M, Punzi L, Sebastiani GD, Touitou I, Doria A. Galeazzi M, et al. Clin Exp Rheumatol. 2006 Jan-Feb;24(1 Suppl 40):S79-85. Clin Exp Rheumatol. 2006. PMID: 16466630 Review.
Antiphospholipid syndrome's genetic and epigenetic aspects.
Iuliano A, Galeazzi M, Sebastiani GD. Iuliano A, et al. Among authors: galeazzi m. Autoimmun Rev. 2019 Sep;18(9):102352. doi: 10.1016/j.autrev.2019.102352. Epub 2019 Jul 16. Autoimmun Rev. 2019. PMID: 31323355 Review.
Interleukin-1 Inhibition in Behçet's disease.
Vitale A, Rigante D, Lopalco G, Selmi C, Galeazzi M, Iannone F, Cantarini L. Vitale A, et al. Among authors: galeazzi m. Isr Med Assoc J. 2016 Mar-Apr;18(3-4):171-6. Isr Med Assoc J. 2016. PMID: 27228638 Free article. Review.
Biosimilars vs originators: Are they the same?
Sarzi-Puttini P, Marotto D, Caporali R, Galeazzi M, Atzeni F, Hamar A, Soós B, Szekanecz Z. Sarzi-Puttini P, et al. Among authors: galeazzi m. Autoimmun Rev. 2019 Dec;18(12):102404. doi: 10.1016/j.autrev.2019.102404. Epub 2019 Oct 19. Autoimmun Rev. 2019. PMID: 31639517 Review.
New therapeutic solutions for Behçet's syndrome.
Vitale A, Rigante D, Lopalco G, Emmi G, Bianco MT, Galeazzi M, Iannone F, Cantarini L. Vitale A, et al. Among authors: galeazzi m. Expert Opin Investig Drugs. 2016 Jul;25(7):827-40. doi: 10.1080/13543784.2016.1181751. Epub 2016 May 10. Expert Opin Investig Drugs. 2016. PMID: 27163156 Review.
Diagnosis and classification of relapsing polychondritis.
Cantarini L, Vitale A, Brizi MG, Caso F, Frediani B, Punzi L, Galeazzi M, Rigante D. Cantarini L, et al. Among authors: galeazzi m. J Autoimmun. 2014 Feb-Mar;48-49:53-9. doi: 10.1016/j.jaut.2014.01.026. Epub 2014 Jan 24. J Autoimmun. 2014. PMID: 24461536 Review.
479 results